660 related articles for article (PubMed ID: 7521735)
1. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
2. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
3. Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp.
Feng GS; Shen R; Heng HH; Tsui LC; Kazlauskas A; Pawson T
Oncogene; 1994 Jun; 9(6):1545-50. PubMed ID: 8183548
[TBL] [Abstract][Full Text] [Related]
4. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
5. Direct determination of the sequence recognition requirements of the SH2 domains of SH-PTP2.
Huyer G; Li ZM; Adam M; Huckle WR; Ramachandran C
Biochemistry; 1995 Jan; 34(3):1040-9. PubMed ID: 7530043
[TBL] [Abstract][Full Text] [Related]
6. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp.
Kuhné MR; Pawson T; Lienhard GE; Feng GS
J Biol Chem; 1993 Jun; 268(16):11479-81. PubMed ID: 8505282
[TBL] [Abstract][Full Text] [Related]
7. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2.
Eck MJ; Pluskey S; Trüb T; Harrison SC; Shoelson SE
Nature; 1996 Jan; 379(6562):277-80. PubMed ID: 8538796
[TBL] [Abstract][Full Text] [Related]
8. Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1.
Sugimoto S; Wandless TJ; Shoelson SE; Neel BG; Walsh CT
J Biol Chem; 1994 May; 269(18):13614-22. PubMed ID: 7513703
[TBL] [Abstract][Full Text] [Related]
9. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases.
Feng GS; Hui CC; Pawson T
Science; 1993 Mar; 259(5101):1607-11. PubMed ID: 8096088
[TBL] [Abstract][Full Text] [Related]
10. SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase.
Tauchi T; Feng GS; Shen R; Song HY; Donner D; Pawson T; Broxmeyer HE
J Biol Chem; 1994 May; 269(21):15381-7. PubMed ID: 8195176
[TBL] [Abstract][Full Text] [Related]
11. The crystal structures of the SH2 domain of p56lck complexed with two phosphonopeptides suggest a gated peptide binding site.
Mikol V; Baumann G; Keller TH; Manning U; Zurini MG
J Mol Biol; 1995 Feb; 246(2):344-55. PubMed ID: 7532720
[TBL] [Abstract][Full Text] [Related]
12. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP.
Staubs PA; Reichart DR; Saltiel AR; Milarski KL; Maegawa H; Berhanu P; Olefsky JM; Seely BL
J Biol Chem; 1994 Nov; 269(44):27186-92. PubMed ID: 7525547
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
14. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
Tanaka S; Ito T; Wands JR
J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
[TBL] [Abstract][Full Text] [Related]
15. The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp.
Kazlauskas A; Feng GS; Pawson T; Valius M
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6939-43. PubMed ID: 7688466
[TBL] [Abstract][Full Text] [Related]
16. Identification of a putative Syp substrate, the PDGF beta receptor.
Klinghoffer RA; Kazlauskas A
J Biol Chem; 1995 Sep; 270(38):22208-17. PubMed ID: 7545675
[TBL] [Abstract][Full Text] [Related]
17. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains.
Pluskey S; Wandless TJ; Walsh CT; Shoelson SE
J Biol Chem; 1995 Feb; 270(7):2897-900. PubMed ID: 7531695
[TBL] [Abstract][Full Text] [Related]
18. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways.
Tauchi T; Feng GS; Shen R; Hoatlin M; Bagby GC; Kabat D; Lu L; Broxmeyer HE
J Biol Chem; 1995 Mar; 270(10):5631-5. PubMed ID: 7534299
[TBL] [Abstract][Full Text] [Related]
19. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.
Marengère LE; Waterhouse P; Duncan GS; Mittrücker HW; Feng GS; Mak TW
Science; 1996 May; 272(5265):1170-3. PubMed ID: 8638161
[TBL] [Abstract][Full Text] [Related]
20. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling.
Keilhack H; Tenev T; Nyakatura E; Godovac-Zimmermann J; Nielsen L; Seedorf K; Böhmer FD
J Biol Chem; 1998 Sep; 273(38):24839-46. PubMed ID: 9733788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]